tiprankstipranks
Trending News
More News >

Beijing Airdoc Gains CSRC Approval for H Share Circulation

Story Highlights
  • Beijing Airdoc Technology received CSRC approval for full circulation of unlisted shares.
  • The approval allows conversion of over 50 million shares into tradable H shares on the Hong Kong Stock Exchange.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Beijing Airdoc Gains CSRC Approval for H Share Circulation

Confident Investing Starts Here:

An announcement from Beijing Airdoc Technology Co. Ltd. Class H ( (HK:2251) ) is now available.

Beijing Airdoc Technology Co., Ltd. has received approval from the China Securities Regulatory Commission (CSRC) for the full circulation of its domestic unlisted shares. This approval allows 26 shareholders to convert over 50 million unlisted shares into H shares, which can be listed and traded on the Hong Kong Stock Exchange. This move is expected to enhance the company’s market presence and liquidity, although further procedural steps are required before completion.

More about Beijing Airdoc Technology Co. Ltd. Class H

Beijing Airdoc Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, focusing on technology development. The company is involved in the healthcare industry, providing AI-driven medical solutions and services.

YTD Price Performance: -4.87%

Average Trading Volume: 180,665

Technical Sentiment Signal: Buy

Current Market Cap: HK$1.55B

See more data about 2251 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1